Vyvanse (lisdexamfetamine) is a central nervous system stimulant that acts as a dopamine and norepinephrine reuptake inhibitor, potentially modulating neural hyperactivity and sensory processing in Visual Snow Syndrome. By enhancing neurotransmitter availability and improving cortical signal-to-noise ratio, it may help reduce visual static and perceptual disturbances associated with the condition.